Vizient Presents on Radiopharmaceutical Trends at 2017 Mo-99 Topical Meeting



"Can the SPECT Nuclear Imaging Modality be Sustained?"

IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. announces Leah Gannon, MBA, senior portfolio executive, pharmacy sourcing operations will present on industry dynamics that affect radiopharmaceuticals at the National Nuclear Security Administration’s (NNSA) 2017 Mo-99 Topical Meeting, hosted by Argonne National Laboratory in Montreal, Sept. 10-13.

The Mo-99 Topical Meeting serves as a workshop where international and domestic policy and technical experts can gather to present and discuss progress toward achieving the production of Mo-99 without the use of highly enriched uranium (HEU) in support of nonproliferation objectives and global reliability of supply. View the agenda here.

Gannon will present on Tuesday, Sept. 12 at 8:30 a.m. ET and will provide an overview of several factors that are currently influencing the radiopharmaceutical supply chain from a group purchasing perspective: secure supply of medical isotopes, price sensitivity and reimbursement, and compliance with new regulatory requirements. She will also discuss Vizient’s commitment to support non-HEU adoption and advocacy efforts related to pricing stability and appropriate models for reimbursement.

The presentation coincides with the release of the new Vizient white paper, “Can the SPECT Nuclear Imaging Modality be Sustained?” The white paper examines the impact on the cost of radiopharmaceutical procurement after the conversion of medical isotopes from HEU to other alternatives. It also looks at the effect of proprietary product price increase, possible regulatory changes, and the issues health care organizations face regarding new payment models and declining reimbursements in the nuclear medicine space.

About Vizient, Inc.

Vizient, Inc., the largest member-driven health care performance improvement company in the country, provides innovative data-driven solutions, expertise and collaborative opportunities that lead to improved patient outcomes and lower costs. Vizient’s diverse membership base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents more than $100 billion in annual purchasing volume. The Vizient brand identity represents the integration of VHA Inc., University HealthSystem Consortium and Novation, which combined in 2015, as well as MedAssets’ Spend and Clinical Resource Management (SCM) segment, including Sg2, which was acquired in 2016. In 2017, Vizient again received a World’s Most Ethical Company designation from the Ethisphere Institute. Vizient’s headquarters are in Irving, Texas, with locations in Chicago and other cities across the United States. Please visit as well as our newsroom, blog, Twitter, LinkedIn and YouTube pages for more information about the company.


Vizient, Inc.
Angie Boliver, 972-830-7961

Related Materials